Results 281 to 290 of about 305,562 (334)

Combination therapy of TACE and PEI, TACE and RFA, and PEI and RFA for treatment of HCC

, 2014
Seong Woo Jeon, Jung Hyeok Kwon, Mi Jeong Kim   +2 more
openalex   +1 more source

STOML2 interacts with PHB to activate the MEK/ERK signaling pathway and mediates autophagy‑related proteins in the progression of hepatocellular carcinoma. [PDF]

Int J Mol Med
Hu H, Zhang H, Han S, Chen J, Xie Y.
europepmc   +1 more source

新しい診断・薬の情報 エプクルーサ配合錠 : HCC既往例のDAA治療後再発からみたC型非代償性肝硬変の抗ウイルス治療の意義

, 2019
優 村岡, 光明 佐藤, 信幸 榎本
openalex   +1 more source

Resistance of first-line targeted drugs in hepatocellular carcinoma: the epigenetic regulation mechanisms. [PDF]

Cell Death Dis
Qi D, Qin Y, Zhu H, Li Y, Han S.
europepmc   +1 more source

LRRC1 Promotes Angiogenesis Through Regulating AKT/GSK3β/β-Catenin/VEGFA Signaling Pathway in Hepatocellular Carcinoma. [PDF]

Cells
Liu H, Liu Z, Xie P, Liu Z, Zhang Y, Cao L, Shang N, Chen M, Feng H, Guan X, Dai G.   +10 more
europepmc   +1 more source

Circulating Fibroblast Growth Factor 21 (FGF21) as a Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma. [PDF]

J Hepatocell Carcinoma
Eid JR, Yalciner M, Xiao L, Sun R, Kannan MK, Hassan M, Rashid A, Chamseddine S, Tran Cao HS, Amin HM, Kaseb AO.   +10 more
europepmc   +1 more source

Evolving epidemiology of HCC in Spain

Margarita Sala, Sonia Pascual, Montserrat Roca, Ana Matilla, Marta Campos, Manuel Delgado, M.T. Ferrer, J.L. Montero, Jesús M. González‐Santiago, Antonio Guerrero, Carles Aracil, Carlos Rodríguez de Lope, Marta Romero-Gutiérrez, Miguel Sogbe, Sergio Vázquez-Rodríguez, Javier Fuentes, Beatriz Mínguez, Luis Cortés, Nicolau Vallejo‐Senra, Paloma Rendón, Ariadna Clos, Dácil Díaz-Bethencourt, Araceli Sanchez, Raisa Quiñones Castro, Javier Bustamante, Christie Perelló, Juan José Urquijo Ponce, Hernán Andreu Serra, Camilo Julio Llamoza-Torres, Silvia Montoliu, Cristina Fernández Marcos, A. Guiberteau, Manuel Hernández‐Guerra, Mercedes Vergara, Alexia María Fernández-López, María Paz Valer López-Fando, María Luisa Gutiérrez-García, Tania Hernáez-Alsina, S. Coll, Berta Cuyàs, María Julia Morillas, S. Olmedo, Miguel Fernández‐Bermejo, Mercè Roget, Ilda Moutinho Anciães Ramos, Gemma Pacheco Del Río, Raimón Rifà, Pilar Conde Gacho, Mónica Llorente Barrio, Mariano Gómez‐Rubio, Irene Peñas, Isabel Serra, Alba Cachero, María Reig, Álvaro Giráldez Gallego, Marta Guerrero, José Xavier Segarra Ortega, José Luis Lledó, Álvaro Díaz‐González, Carolina Delgado, Mercedes Iñarrairaegui, Mónica Rodríguez-González, María T. Lázaro, María Bermúdez-Ramos, Alberto Lué, Esther Molina, Manuel Alberto Macías-Rodríguez, Manuel Rodríguez, Valentina Chiminazzo, Marı́a Varela   +69 more
openalex   +1 more source

INTERLEUKIN-6 AND INTERLEUKIN-10 AS BIOMARKERS OF HEPATOCELLULAR CARCINOMA PROGRESSION: A CROSS-SECTIONAL ANALYSIS OF NUTRITIONAL, CYTOKINE AND SURVIVAL PARAMETERS. [PDF]

Arq Gastroenterol
Faria IC, Monici LT, Pavan CR, Almeida JRS, Faria SHDM, Sevá-Pereira T.   +5 more
europepmc   +1 more source

Diagnostic significance of gut Microbiome dysbiosis and biomarker expression in Egyptians with hepatocellular carcinoma. [PDF]

Sci Rep
Marawan AE, Elmetwally OA, Marwan MM, El-Sokkary MMA, Abass SA, Eissa LA.   +5 more
europepmc   +1 more source

Histidine ammonia lyase expression characteristics in primary liver cancer: hepatocellular carcinoma and cholangiocarcinoma. [PDF]

Discov Oncol
Fiadjoe HK, Hoteit T, Jones HP, Park IW, Chaudhary P.   +4 more
europepmc   +1 more source